← BackEnvista Holdings Corp · Dental Equipment & SuppliesNVST
Low riskNext report: In 1 days (est.)
The short versionA profitable company with steady sales. Institutions are adding.
Going well
- Profitable
- Brings in more cash than it spends
- Buying back shares: share count down 4.7% in 3 years
Money moves
- No insider buying or selling in the last 30 days
- Institutions added 6.6% to their holdings in the quarter ending June 2026 (191 bought, 185 sold)
- Held by Ray Dalio (Bridgewater)
Facts from SEC filings, not a recommendation.
What the price means
Price as of Oct 26
$23.65+0.3% that day
- Company value
- $3.8B
- Share price times all shares
- Price vs profit (P/E)
- 40.8x
- You pay about $41 for each $1 of yearly profit
- Price vs sales
- 1.3x
- Company value is 1.3 times a year of sales
- Cash vs value
- 30%
- Cash as a share of company value
- Debt vs value
- 38%
- Debt as a share of company value
From NVST's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.
The business over time
Last 12 quarters, from SEC filings
Sales, Jul '26$730.5M+7.1% vs a year earlier
Sep '23Tap a barJul '26
Last 12 months: $2.9B, up 12% from the 12 months before. Over 5 years, sales grew about 7.1% a year.
Business quality
The checklist Warren Buffett-style investors use. Annual numbers for 2025.- MissReturn on equity 15%+Earns a lot on the money owners have in the business.1.6%
- PassDebt under half of equityNot relying on borrowed money.0.47x equity
- MissNet margin 10%+Keeps at least 10 cents of profit from each dollar of sales.1.7%
- MissProfitable every yearSteady profits, not one good year.7 of 9 years
- PassFree cash flow positiveBrings in more cash than it spends to run and grow.$230.4M
- PassShare count not growingNot diluting owners. Falling means buybacks.-4.7% in 3 years
- PassGross margin 40%+Pricing power: sells for well above what it costs to make.54.7%
- Revenue
- $2.7B
- +8.3% vs prior year
- 5-year growth
- +7.1%/yr
- revenue, per year
- Total debt
- $1.4B
- 0.47x equity
- Current ratio
- 2.38x
- short-term assets / bills due
From annual reports filed with the SEC. A checklist is a starting point for research, not a verdict.
Latest quarter
Quarter ended Jul 3, 2026- Revenue
- $730.5M
- +7.1% YoY
- EPS
- $0.33
- vs $0.16
- Op. margin
- 11.0%
- +4.2 pts
- Gross margin
- 55.7%
- +1.5 pts
- Free cash flow
- $104.3M
- Share count
- -3.4%
- vs a year ago
Insider rating
Last 90 days
No open-market insider buys or sells in the last 90 days.
Weekly insider trendNo trades to chart yet.
Filing buzz
Last 7 days vs normal
0/ 100
- This week
- 1
- Normal week
- 1.0
- vs normal
- 1.0x
SEC filings of any kind. 50 means a normal week.
Institutional ownership
▲Accumulating+6.6%Institutions added 6.6% to their holdings. 191 bought, 185 sold.
Shares held by institutions189.9M
Sep '24Jun '26
Share count growthYearly rate, last 3 years
-0.7%Cash runwayAt last year's cash burn
Cash flow positiveDebt to equityLatest balance sheet: debt compared with what owners have
0.5x · $1.4B debtShares outstandingLatest reported
161MNext reportIn 1 days (est.)Estimated from the same quarter last year
- Results filedAug 5
- Results filedMay 6
- Results filedFeb 5
- Results filedOct 29, 2025
- Results filedJul 31, 2025
Flags and big holders
Offerings 6 months, flags 12 months, holders 90 days
No offerings, red flags or new big holders. Clean record.
Insider trades
Open-market buys and sells, last 90 days
No open-market buys or sells in 90 days. Grants and option exercises are left out.
"Owns after" is the insider's holding right after the trade. Pre-planned (10b5-1) sales are set up months ahead, a weaker signal.
Latest filings
Straight from SEC EDGAR
Shares withheld for taxesStefan NilssonPresident, Nobel Biocare
804 shares at $27.47 · $22K
- -1% of holdings
- Now owns 61,560 shares
- Filed 2 days after trade
Shares withheld for taxesEric D. HammesChief Financial Officer
10,885 shares at $27.47 · $299K
- -10% of holdings
- Now owns 99,913 shares
- Filed 2 days after trade
Shares withheld for taxesRobert BefidiPresident, Diagnostics
5,147 shares at $27.47 · $141K
- -10% of holdings
- Now owns 45,785 shares
- Filed 2 days after trade
Shares withheld for taxesVeronica AcurioPresident, Orthodontics
7,710 shares at $27.47 · $212K
- -14% of holdings
- Now owns 48,806 shares
- Filed 2 days after trade
SoldMischa ReisSVP, Strategy & Bus. Dev.
8,000 shares at $27.50 · $220K
- -23% of holdings
- Now owns 27,321 shares
- Pre-planned sale (10b5-1)
- Filed 4 days after trade
Stock awardEric D. HammesChief Financial Officer
47,970 shares
- Now owns 47,970 shares
- Performance Share Unit
- Filed 2 days after trade